TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
79,479
|
79,806
|
67,075 |
Financial expenses |
666
|
1,397
|
12 |
Earnings before taxes |
-3,382
|
-2,477
|
2,491 |
EBITDA |
-1,937
|
-1,087
|
2,525 |
Total assets |
28,128
|
30,177
|
32,258 |
Current assets |
23,861
|
26,431
|
32,049 |
Current liabilities |
12,858
|
13,325
|
13,823 |
Equity capital |
2,670
|
1,052
|
1,247 |
- share capital |
200
![]() |
200
![]() |
200 |
Employees (average) |
50
|
45
|
34 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
9.5%
|
3.5%
|
3.9% |
Turnover per employee |
1,590
|
1,773
|
1,973 |
Profit as a percentage of turnover |
-4.3%
|
-3.1%
|
3.7% |
Return on assets (ROA) |
-9.7%
|
-3.6%
|
7.8% |
Current ratio |
185.6%
|
198.4%
|
231.9% |
Return on equity (ROE) |
-126.7%
|
-235.5%
|
199.8% |
Change turnover |
-327
|
12,731
|
7,412 |
Change turnover % |
0%
|
19%
|
12% |
Chg. No. of employees |
5
|
11
|
7 |
Chg. No. of employees % |
11%
|
32%
|
26% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.